Skip to main content
915 TLDR
Health
1 read

Supreme Court to Review Roundup Cancer Claims Affecting Thousands

KVIA••CNN Newsource
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

The U.S. Supreme Court has agreed to hear a pivotal case regarding claims that the pesticide Roundup caused cancer in numerous individuals. This decision could determine whether federal regulations preempt state lawsuits, potentially blocking over 100,000 claims against Monsanto, now owned by Bayer. The case stems from a $1.25 million jury verdict for John Durnell, who alleges that his non-Hodgkin lymphoma was caused by Roundup exposure. The Supreme Court is expected to hear arguments in the spring, with significant implications for both agriculture and public health. The Trump administration is backing Monsanto's position, complicating the political landscape surrounding the case.

Key Details: • Supreme Court to hear arguments in spring 2024. • Over 100,000 claims against Monsanto may be impacted. • John Durnell's case resulted in a $1.25 million jury verdict. • Monsanto argues federal law preempts state claims. • EPA has consistently stated glyphosate does not cause cancer.

supreme-court roundup cancer-claims monsanto glyphosate

People & Organizations

Trump administrationRobert F. Kennedy Jr.Environmental Protection AgencyJohn DurnellMonsantoBayer

Related Articles

KTSM•Feb 24

El Paso Center for Diabetes to Host Overnight Camps for Teens in 2026

The El Paso Center for Diabetes is set to revive its youth overnight camps, with the first camp scheduled for April 10-12, 2026. This camp will cater to teenagers aged 12 to 17 and will take place in Angus, New Mexico, approximately 16 miles from El Paso. These camps aim to provide education and support for young individuals managing diabetes, fostering a sense of community and empowerment. Parents and guardians should mark their calendars for this opportunity to enhance their children's health and social skills.

Health
1 min read
KVIA•Feb 24

Novo Nordisk Cuts Prices of Ozempic and Wegovy by 50% Starting 2027

Novo Nordisk has announced a significant reduction in the list prices of its popular diabetes and weight loss medications, Ozempic, Wegovy, and Rybelsus, by up to 50% starting in 2027. The current list price for Wegovy is $1,349, while Ozempic and Rybelsus are priced at $1,028. This price cut aims to improve accessibility for patients, particularly those with high deductibles or co-insurance plans. The move comes as Novo Nordisk competes with Eli Lilly, which has gained market share in the obesity medication sector. Despite the list price reductions, self-pay prices will remain unaffected. The company recently reported disappointing trial results for its next-generation obesity drug, contributing to a decline in its stock price.

Health
1 min read
KVIA•Feb 24

Trump's Glyphosate Order Sparks Controversy Among Health Advocates in El Paso

An executive order by President Trump has declared glyphosate, a widely used herbicide, essential for national security and economic stability, which has drawn ire from health advocates, particularly those associated with the 'Make America Healthy Again' (MAHA) movement. The order emphasizes the need for a domestic supply of glyphosate, despite ongoing health concerns about its potential carcinogenic effects. Critics, including Zen Honeycutt of Moms Across America, argue that this move may protect Monsanto from lawsuits related to glyphosate's health risks. The order coincides with Bayer's proposed $7.25 billion settlement over cancer claims linked to Roundup, the product containing glyphosate. Health experts warn of the herbicide's risks, especially to children, as studies indicate increased cancer risks associated with exposure.

Health
1 min read
KVIA•Feb 24

How Technology is Enhancing Patient Engagement in Healthcare

Recent advancements in technology are significantly improving the way patients interact with their healthcare providers. Tools like home blood pressure monitors, glucometers, and smartwatches allow patients to collect vital health data, which can be shared during appointments to enhance treatment plans. For example, accurate blood pressure readings require validated devices and specific techniques to ensure reliability. This shift towards patient-generated data is transforming healthcare from a reactive to a proactive model, enabling more personalized care. However, while technology plays a crucial role, it is essential to maintain the personal connection during in-person visits.

Health
1 min read